Wettig Thane bought FGEN
February 21, 2024 · Form 4 insider transaction
Wettig Thane bought 166,000 shares of FibroGen Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
166,000
Price
$0.00
Total value
N/A
InsiderWettig Thane
RoleOfficer, Director
CompanyFibroGen Incorporated (FGEN)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 21, 2024
Filing dateFebruary 23, 2024
Shares owned after423,932
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the grant of restricted stock units (RSUs). Twenty-five percent of the RSUs will vest on March 6, 2025, and the remainder of the RSUs will vest in equal amounts quarterly thereafter for the following three years.